Download PDF

Other users also viewed these articles

Correlation of X chromosome inactivation with clinical presentation of Fabry disease in a case report Pablo Rodríguez Doyágüez, Mónica Furlano, Elisabet Ars Criach, Yolanda Arce, Lluís Guirado, Roser Torra Balcells
10.1016/j.nefroe.2024.01.018
Predictors of outcome in a Spanish cohort of patients with Fabry disease on enzyme replacement therapy Marian Goicoechea, Francisco Gomez-Preciado, Silvia Benito, Joan Torras, Roser Torra, Ana Huerta, Alejandra Restrepo, Jessica Ugalde, Daniela Estefania Astudillo, Irene Agraz, Manuel Lopez-Mendoza, Gabriel de Arriba, Elena Corchete, Borja Quiroga, Maria Jose Gutierrez, Maria Luisa Martin-Conde, Vanessa Lopes, Carmela Ramos, Irene Mendez, Mercedes Cao, Fernando Dominguez, Alberto Ortiz
10.1016/j.nefroe.2022.01.003
Fabry disease as a trigger of immune-mediated glomerular disease: Clinical hypotheses and literature review Javier Martínez de Victoria Carazo, Haylen Marin, Francisco Javier De la Hera Fernández, Carlos Mañero Rodríguez, César Ramírez Tortosa, José Luís Callejas Rubio
10.1016/j.nefroe.2025.04.010